Articles dans des revues avec comité de lecture (402)
  1. 145. Deleporte, A., Paesmans, M., Garcia, C., Vandeputte, C., Lemort, M., Engelholm, J. L., Hoerner, F., Aftimos, P., Awada, A., Charette, N., Machiels, G., Piccart-Gebhart, M., Flamen, P., & Hendlisz, A. (2014). Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: The CORIOLAN study. BMC cancer, 14(1), 385. doi:10.1186/1471-2407-14-385
  2. 146. Sydris, S., Aftimos, P., Georgala, A., Sirtaine, N., Awada, A., & Gil, T. (2014). A Rare Case of Prostatic Extra Gonadal Germ Cell Tumor in a Young Adult: Review of the Literature. JBR Journal of Clinical Diagnosis and Research, 2(2), 1000112. doi:10.4172/2376-0311.1000112
  3. 147. Elalamy, I., Canon, J.-L., Bols, A., Lybaert, W., Duck, L., Jochmans, K., Bosquée, L., Peeters, M., Awada, A., Clement, P., Holbrechts, S., Baurain, J.-F., Mebis, J., & Nortier, J. (2014). Thrombo-embolic events in cancer patients with impaired renal function. Journal of blood disorders & transfusion, 5(4), 202. doi:10.4172/2155-9864.1000202
  4. 148. Aftimos, P., Barthélémy, P., & Awada, A. (2014). Molecular biology in medical oncology: Diagnosis, prognosis, and precision medicine. Discovery medicine, 17(92), 81-91.
  5. 149. Krayem, M., Journé, F., Wiedig, M., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2014). Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib. European journal of cancer. doi:10.1016/j.ejca.2014.01.021
  6. 150. Wildiers, H., Denys, H., Fontaine, C., & Awada, A. (2014). Adjuvant and neoadjuvant chemotherapy regimens in breast cancer: Summary from the BSMO breast cancer task force meeting. Belgian journal of medical oncology, 8(4), 116-124.
  7. 151. Awada, A., & Aftimos, P. (2014). Foreword for the edition of Treatment Strategies. Oncology, 4(1), 9.
  8. 152. Thomas, F., Desmedt, C., Aftimos, P., & Awada, A. (2014). Impact of tumor sequencing on the use of anticancer drugs. Current opinion in oncology, 26(3), 347-356. doi:10.1097/CCO.0000000000000078
  9. 153. Awada, A., Nicaise, C., Ena, S., Schandené, L., Rasschaert, J., Ristea-Popescu, A. I., Gangji, V., & Soyfoo, M. S. (2014). Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome. Annals of the Rheumatic Diseases, 73, 1259-1263. doi:10.1136/annrheumdis-2012-203187
  10. 154. Raymond, É. E., Faivre, S., Alexandre, J., Goldwasser, F., Besse-Hammer, T., Awada, A., Gianella-Borradori, A., Jego, V., Trandafir, L., & Rejeb, N. (2014). A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors. Investigational new drugs, 32(1), 94-103. doi:10.1007/s10637-013-9950-y
  11. 155. Ades Moraes, F., Zardavas, D., Aftimos, P., & Awada, A. (2014). Anticancer drug development: Moving away from the old habits. Current opinion in oncology, 26(3), 334-339. doi:10.1097/CCO.0000000000000076
  12. 156. Bartsch, R., Berghoff, A. S., Zielinski, C., Gnant, M., Frings, S., Marty, M., Awada, A., Conte, P., Dickin, S., Enzmann, H., Hasmann, M., Hendriks, H. H., Llombart, A., Massacesi, C., Von Minckwitz, G., Pénault-Llorca, F., Scaltriti., M., Yarden, Y., & Zwierzina, H. (2014). Present and future breast cancer management-bench to bedside and back: A positioning paper of academia, regulatory authorities and pharmaceutical industry. Annals of oncology, 25(4), mdt531, 773-780. doi:10.1093/annonc/mdt531
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 Suivant >>